Yes, some patients may discuss switching from tirzepatide to semaglutide depending on tolerance, side effects, availability, cost, clinical response or provider recommendation
Improper handling or contaminated products may increase the risk of complications
If you're considering a switch, discussing your genetic predisposition context with your provideralongside your current treatment outcomes and the real financial or access barriers driving the decisioncreates a more complete clinical picture
Common incretin-related effects discussed in the broader GLP-1 and metabolic drug class may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort, but trial observations do not establish safe personal use of a research peptide
If You are More Than 5 Days Late If you have missed your dose by more than 5 days, the standard recommendation is usually to skip the dose entirely
1 PBH is a debilitating condition with no approved treatment options, and we look forward to advancing this critical work with avexitide into Phase III for individuals with PBH based on the totality of data from five clinical trials, and informed by our ongoing work to address endocrine and metabolic aspects of Wolfram syndrome